2025 second_quarter Filing

Implementation and reauthorization of the Food and Drug Administration (FDA) over-the-counter (OTC) drug approval process reforms for sunscreen ingredients included in the Coronavirus Aid, Relief, and Economic Security (CARES Act; Public Law 116-136); FDA proposed order on OTC sunscreen active ingredients; FDA jurisdiction regarding the safety and efficacy and OTC sunscreen active ingredients; sunscreen provisions in the Fiscal Year 2026 appropriations for the Food and Drug Administration (FDA) (H.R. 4121 and S. 2256); use of sunscreen in schools to prevent sunburns in children; reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA); the SAFE Sunscreen Standards Act (H.R. 3686).